<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00890000_2</Organism_ID>
  <Organism>HCV</Organism>
  <Organism_Latin>Hepatitis C virus</Organism_Latin>
  <UniProt_ID>O92972</UniProt_ID>
  <Seq_Length>3010</Seq_Length>
  <Molecule_Weight>326767</Molecule_Weight>
  <EBI_ID>EBI-710506</EBI_ID>
  <Function_Summary>Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Thought to play a role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Could mediate apoptotic pathways through association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptor-induced apoptosis remains controversial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Seric core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. Alters lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage. Core protein induces up-regulation of FAS promoter activity, and thereby probably contributes to the increased triglyceride accumulation in hepatocytes (steatosis) (By similarity).E1 and E2 glycoproteins form a heterodimer that is involved in virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. E1/E2 heterodimer binds to human LDLR, CD81 and SCARB1/SR-BI receptors, but this binding is not sufficient for infection, some additional liver specific cofactors may be needed. The fusion function may possibly be carried by E1. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection (By similarity).P7 seems to be a heptameric ion channel protein (viroporin) and is inhibited by the antiviral drug amantadine. Also inhibited by long-alkyl-chain iminosugar derivatives. Essential for infectivity (By similarity).Protease NS2-3 is a cysteine protease responsible for the autocatalytic cleavage of NS2-NS3. Seems to undergo self-inactivation following maturation (By similarity).NS3 displays three enzymatic activities: serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A and NS5A-NS5B. NS3/NS4A complex also prevents phosphorylation of human IRF3, thus preventing the establishment of dsRNA induced antiviral state. NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand. Cleaves and inhibits the host antiviral protein MAVS (By similarity).NS4B induces a specific membrane alteration that serves as a scaffold for the virus replication complex. This membrane alteration gives rise to the so-called ER-derived membranous web that contains the replication complex (By similarity).NS5A is a component of the replication complex involved in RNA-binding. Its interaction with Human VAPB may target the viral replication complex to vesicles. Down-regulates viral IRES translation initiation. Mediates interferon resistance, presumably by interacting with and inhibiting human EIF2AK2/PKR. Seems to inhibit apoptosis by interacting with BIN1 and FKBP8. The hyperphosphorylated form of NS5A is an inhibitor of viral replication (By similarity).NS5B is an RNA-dependent RNA polymerase that plays an essential role in the virus replication (By similarity).</Function_Summary>
  <Catalytic_Mechanism>Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.@@Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).@@NTP + H(2)O = NDP + phosphate.@@ATP + H(2)O = ADP + phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF07652:Flavi_DEAD@@PF01543:HCV_capsid@@PF01542:HCV_core@@PF01539:HCV_env@@PF01560:HCV_NS1@@PF01538:HCV_NS2@@PF01006:HCV_NS4a@@PF01001:HCV_NS4b@@PF01506:HCV_NS5a@@PF08300:HCV_NS5a_1a@@PF08301:HCV_NS5a_1b@@PF12941:HCV_NS5a_C@@PF02907:Peptidase_S29@@PF00998:RdRP_3</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>19</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>4</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>p8</Alias>
      <Alias>Envelope glycoprotein E2</Alias>
      <Alias>RNA-directed RNA polymerase</Alias>
      <Alias>p56</Alias>
      <Alias>gp32</Alias>
      <Alias>NS4B</Alias>
      <Alias>Non-structural protein 4B</Alias>
      <Alias>Capsid protein C</Alias>
      <Alias>gp68</Alias>
      <Alias>Core protein p21</Alias>
      <Alias>Non-structural protein 4A</Alias>
      <Alias>Core protein p19</Alias>
      <Alias>Protease NS2-3</Alias>
      <Alias>p68</Alias>
      <Alias>NS5A</Alias>
      <Alias>Non-structural protein 5A</Alias>
      <Alias>p23</Alias>
      <Alias>Serine protease NS3</Alias>
      <Alias>NS1</Alias>
      <Alias>NS3P</Alias>
      <Alias>p7</Alias>
      <Alias>gp70</Alias>
      <Alias>Hepacivirin</Alias>
      <Alias>NS4A</Alias>
      <Alias>p21</Alias>
      <Alias>gp35</Alias>
      <Alias>p70</Alias>
      <Alias>p27</Alias>
      <Alias>Envelope glycoprotein E1</Alias>
      <Alias>NS5B</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type exopeptidase activity</Keyword>
      <Ontology_ID>GO:0070008</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004197</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Small transmembrane protein that homo-oligomerizes to form a viral ionic channel usually expressed in the viral envelope and host cell membranes. These channels affect membrane permeability to ions and play an important role in facilitating virus entry, assembly and release, as well as modulating the ionic homeostasis of host cells. Viral ionic channels are not necessarily required for the production of infectious virions, although their expression usually significantly increases growth. During influenza A virus entry for example, the M2 proton channel allows protons from the acidic endosome to enter the enveloped virion, initiating pH-dependent uncoating of the genome. In certain influenza A subtypes, M2 also equilibrates the intraluminal pH of the trans-Golgi network with the cytoplasm, preventing premature conformational changes in the viral fusion protein during budding.</Detail>
      <Keyword>Viral ionic channel</Keyword>
      <Ontology_ID>KW-1182</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any nucleic acid.</Detail>
      <Keyword>Nucleic acid binding</Keyword>
      <Ontology_ID>GO:0003676</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.</Detail>
      <Keyword>Ion channel activity</Keyword>
      <Ontology_ID>GO:0005216</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.</Detail>
      <Keyword>SH3 domain binding</Keyword>
      <Ontology_ID>GO:0017124</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.</Detail>
      <Keyword>ATP-dependent helicase activity</Keyword>
      <Ontology_ID>GO:0008026</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a DNA or RNA helix.</Detail>
      <Keyword>Helicase activity</Keyword>
      <Ontology_ID>GO:0004386</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The action of a molecule that contributes to the structural integrity of a complex or assembly within or outside a cell.</Detail>
      <Keyword>Structural molecule activity</Keyword>
      <Ontology_ID>GO:0005198</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a nucleotidyl group to a reactant.</Detail>
      <Keyword>Nucleotidyltransferase activity</Keyword>
      <Ontology_ID>GO:0016779</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template.</Detail>
      <Keyword>RNA-directed RNA polymerase activity</Keyword>
      <Ontology_ID>GO:0003968</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The cellular synthesis of DNA on a template of RNA.</Detail>
      <Keyword>Transcription, RNA-dependent</Keyword>
      <Ontology_ID>GO:0006410</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of the type I, II and III interferon pathways by inhibiting the STAT1 protein. Upon viral infection, STAT1 is activated by IFN-gamma, IFN-alpha/beta, or IFN-lambda that bind to specific cell surface receptors. While IFN-gamma induces STAT1 homodimerization, IFN-alpha/beta and IFN-lambda stimulate heterodimerization of STAT1 and STAT2, both leading to STAT1 nuclear localization and subsequent induction of IFN-stimulated genes. Many viruses interfere with STAT1 activation, often by preventing STAT1 phosphorylation and nuclear localization.</Detail>
      <Keyword>Inhibition of host STAT1 by virus</Keyword>
      <Ontology_ID>KW-1105</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the specific binding of a viral antireceptor to a cell surface receptor.</Detail>
      <Keyword>Virion attachment to host cell surface receptor</Keyword>
      <Ontology_ID>GO:0019062</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the modulation of host cell cycle progression by dysregulating the G1/S transition. Some viruses benefit from an arrest in G1 to S phase transition, while others force through S phase to favor their own replication.</Detail>
      <Keyword>G1/S host cell cycle checkpoint dysregulation by virus</Keyword>
      <Ontology_ID>KW-1078</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate defense by inhibiting the MAVS protein. During viral replication, dsRNA is produced and detected by DDX58/RIG-I or IFIH1/MDA5 that will activate MAVS to coordinate pathways leading to induction of antiviral cytokines. Several viral proteins including NS3/4A from Hepatitis C, or protease 3C from hepatitis A virus, cleave MAVS to abrogate its activity.</Detail>
      <Keyword>Inhibition of host MAVS by virus</Keyword>
      <Ontology_ID>KW-1097</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the merging of the virion membrane with the host membrane during viral penetration or egress in host cell. Viral fusion proteins drive this fusion reaction by undergoing a major conformational change that is triggered by interactions with the target cell. The specific trigger depends on the virus and can be exposure to low pH in the endocytic pathway or interaction of the virion with the host receptor(s).</Detail>
      <Keyword>Fusion of virus membrane with host membrane</Keyword>
      <Ontology_ID>KW-1168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in virus internalization by the host cell via receptor-mediated endocytosis. Receptor mediated endocytosis can occur via: clathrin-mediated endocytosis, caveolin-mediated endocytosis or clathrin- and caveolae-independent endocytosis.</Detail>
      <Keyword>Receptor mediated endocytosis of virus by host</Keyword>
      <Ontology_ID>KW-1164</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Ion transport</Keyword>
      <Ontology_ID>GO:0006811</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate defense by inhibiting the interferon signaling pathway leading to the production of interferon-induced genes. Interferons bind to the IFN receptors (IFNAR) on the cell surface and activate Jak/Tyk kinases. These kinases phosphorylate STAT1 and STAT2 that translocate to the nucleus and induce the expression of interferon stimulated genes (ISGs). Many viruses interact with components of this pathway to prevent expression of ISGs and inhibit the host immune response.</Detail>
      <Keyword>Inhibition of host interferon signaling pathway by virus</Keyword>
      <Ontology_ID>KW-1114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the entry of the entire virion or its genetic material into the host cell cytoplasm. Entry is achieved through pore formation, membrane fusion and/or endocytosis mechanisms. Penetration reactions occur mainly in five locations: the cell membrane, early and late endosomes, caveosomes, and the ER.</Detail>
      <Keyword>Viral penetration into host cytoplasm</Keyword>
      <Ontology_ID>KW-1162</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate defense by inhibiting the pathway leading to the triggering of interferon-mediated response. This pathway usually starts with the recognition of viral RNA or DNA by host proteins including DDX58 or IFIH1. Then, the signal is transmitted through MAVS and TRAFs leading to the activation and nuclear localization of transcription factors IRF3 and IRF7 to induce IFNalpha/beta transcription and protein production. Many viruses interact with components of this pathway to inhibit production of interferons and establishment of the antiviral state.</Detail>
      <Keyword>Inhibition of host IFN-mediated response initiation by virus</Keyword>
      <Ontology_ID>KW-1113</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.</Detail>
      <Keyword>Protein oligomerization</Keyword>
      <Ontology_ID>GO:0051259</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the activation of host autophagy. Autophagy is a major intracellular pathway in the delivery of cytoplasmic material to lysosomes for degradation. It is also essential for the removal of pathogenic protein aggregates from the cell during infection. Although autophagy is clearly important for antiviral immune response, it can also be activated by viruses and serves as platform for viral replication. Some viruses such as poliovirus, use the autophagic pathway as a nonlytic mechanism for viral release.</Detail>
      <Keyword>Activation of host autophagy by virus</Keyword>
      <Ontology_ID>KW-1072</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate defense by inhibiting TRAF proteins. After viral infection, the cellular signaling pathway leading to production of interferons is activated and several TRAF family members including TRAF2, TRAF3, and TRAF5 participate in this cascade. Many viruses encode protein able to interact with TRAF members to inhibit their antiviral activity.</Detail>
      <Keyword>Inhibition of host TRAFs by virus</Keyword>
      <Ontology_ID>KW-1110</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process, either active or passive, by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.</Detail>
      <Keyword>Evasion by virus of host immune response</Keyword>
      <Ontology_ID>GO:0030683</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any virus-induced change in the morphological, biochemical, or growth parameters of a cell.</Detail>
      <Keyword>Transformation of host cell by virus</Keyword>
      <Ontology_ID>GO:0019087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate immune response. Upon viral infection, the innate immune system initially defends the host in a non-specific manner. Many viral proteins interact with and inhibit components the host innate system to replicate more efficiently.</Detail>
      <Keyword>Inhibition of host innate immune response by virus</Keyword>
      <Ontology_ID>KW-1090</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the modulation of host cell cycle. The cell cycle can be divided into four stages: G1, S, G2 and mitosis, while cells resting are termed quiescent cells (G0). Viruses have evolved strategies to modulate cell cycle progression including stimulation of S phase entry from G1 or G0 or cell cycle arrest at G2/M for example. This regulation allows viruses to maximize their own replication.</Detail>
      <Keyword>Modulation of host cell cycle by virus</Keyword>
      <Ontology_ID>KW-1121</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in virus internalization by the host cell via clathrin-mediated endocytosis. In response to an internalization signal, clathrin is assembled on the inside face of the cell membrane to form characteristic invaginations or clathrin coated pits that pinch off through the action of DNM1/Dynamin-1 or DNM2/Dynamin-2. The virus bound to its host cell receptor is internalized into clathrin-coated vesicles (CCV). Endocytic CCV deliver their viral content to early endosomes. The endosomal acidic pH and/or receptor binding usually induces structural modifications of the virus surface proteins that lead to penetration of the endosomal membrane via fusion or permeabilization mechanisms.</Detail>
      <Keyword>Clathrin-mediated endocytosis of virus by host</Keyword>
      <Ontology_ID>KW-1165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process, either active or passive, by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.</Detail>
      <Keyword>Evasion by virus of host immune response</Keyword>
      <Ontology_ID>GO:0030683</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the virion's initiation of infection into a host cell, including internalization and penetration into the host cell cytoplasm, intracellular transport of viral components and genome release to the replication site of the virus.</Detail>
      <Keyword>Initiation of viral infection</Keyword>
      <Ontology_ID>KW-1160</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral surface protein implicated in the binding to specific host surface molecule(s). This binding can lead to virion entry into the host cell, it can trigger signaling pathways, or it can allow the virion to be carried by the host cell to a specific organ.</Detail>
      <Keyword>Viral attachment to host cell</Keyword>
      <Ontology_ID>KW-1161</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the merging of the virus envelope with host endosomal membrane during viral penetration into host cell. Viral fusion proteins drive this fusion reaction by undergoing a major conformational change that is triggered by interactions with the target cell. The specific trigger is mainly endosome acidification which induce activation of the fusion protein by conformational change. This pathway is used by enveloped viruses which are endocytosed and whose fusion protein is usually pH-dependent like influenza A virus, rhabdoviruses, bornaviruses, filoviruses, asfarviridae, flaviviridae, alphaviruses, HIV-1, avian leukosis virus, SARS, 229E, and MHV-2 coronaviruses.</Detail>
      <Keyword>Fusion of virus membrane with host endosomal membrane</Keyword>
      <Ontology_ID>KW-1170</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006355</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2197</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>116</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2201</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>99</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2194</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2204</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>53</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKASERSQPRGRRQPIPKARRPEGRAWAQPGYPWPLYGNEGLGWAGWLLSPRGSRPSWGPTDPRRRSRNLGKVIDTLTCGFADLMGYIPLVGAPLGGAARALAHGVRVLEDGVNYATGNLPGCSFSIFLLALLSCLTIPASAYEVRNVSGIYHVTNDCSNSSIVYEAADVIMHTPGCVPCVREGNSSRCWVALTPTLAARNASVPTTTIRRHVDLLVGTAAFCSAMYVGDLCGSIFLVSQLFTFSPRRHETVQDCNCSIYPGHVSGHRMAWDMMMNWSPTTALVVSQLLRIPQAVVDMVAGAHWGVLAGLAYYSMVGNWAKVLIVALLFAGVDGETHTTGRVAGHTTSGFTSLFSSGASQKIQLVNTNGSWHINRTALNCNDSLQTGFFAALFYAHKFNSSGCPERMASCRPIDWFAQGWGPITYTKPNSSDQRPYCWHYAPRPCGVVPASQVCGPVYCFTPSPVVVGTTDRSGVPTYSWGENETDVMLLNNTRPPQGNWFGCTWMNSTGFTKTCGGPPCNIGGVGNRTLICPTDCFRKHPEATYTKCGSGPWLTPRCLVDYPYRLWHYPCTLNFSIFKVRMYVGGVEHRLNAACNWTRGERCNLEDRDRSELSPLLLSTTEWQILPCAFTTLPALSTGLIHLHQNIVDVQYLYGVGSAFVSFAIKWEYILLLFLLLADARVCACLWMMLLIAQAEAALENLVVLNAASVAGAHGILSFLVFFCAAWYIKGRLAPGAAYAFYGVWPLLLLLLALPPRAYALDREMAASCGGAVLVGLVFLTLSPYYKVFLTRLIWWLQYFITRAEAHMQVWVPPLNVRGGRDAIILLTCAVHPELIFDITKLLLAILGPLMVLQAGITRVPYFVRAQGLIRACMLVRKVAGGHYVQMAFMKLGALTGTYVYNHLTPLRDWAHAGLRDLAVAVEPVVFSAMETKVITWGADTAACGDIILGLPVSARRGKEIFLGPADSLEGQGWRLLAPITAYSQQTRGVLGCIITSLTGRDKNQVEGEVQVVSTATQSFLATCINGVCWTVYHGAGSKTLAGPKGPITQMYTNVDLDLVGWQAPPGARSMTPCSCGSSDLYLVTRHADVIPVRRRGDSRGSLLSPRPVSYLKGSSGGPLLCPSGHVVGVFRAAVCTRGVAKAVDFIPVESMETTMRSPVFTDNSSPPAVPQTFQVAHLHAPTGSGKSTKVPAAYAAQGYKVLVLNPSVAATLGFGAYMSKAHGIDPNIRTGVRTITTGGSITYSTYGKFLADGGCSGGAYDIIICDECHSTDSTTILGIGTVLDQAETAGARLVVLATATPPGSVTVPHPNIEEIGLSNNGEIPFYGKAIPIEAIKGGRHLIFCHSKKKCDELAAKLTGLGLNAVAYYRGLDVSVIPPIGDVVVVATDALMTGFTGDFDSVIDCNTCVTQTVDFSLDPTFTIETTTVPQDAVSRSQRRGRTGRGRSGIYRFVTPGERPSGMFDSSVLCECYDAGCAWYELTPAETSVRLRAYLNTPGLPVCQDHLEFWESVFTGLTHIDAHFLSQTKQAGDNFPYLVAYQATVCARAQAPPPSWDQMWKCLIRLKPTLHGPTPLLYRLGAVQNEVILTHPITKYIMACMSADLEVVTSTWVLVGGVLAALAAYCLTTGSVVIVGRIILSGKPAVVPDREVLYQEFDEMEECASQLPYIEQGMQLAEQFKQKALGLLQTATKQAEAAAPVVESKWRALETFWAKHMWNFISGIQYLAGLSTLPGNPAIASLMAFTASITSPLTTQNTLLFNILGGWVAAQLAPPSAASAFVGAGIAGAAVGSIGLGKVLVDILAGYGAGVAGALVAFKVMSGEVPSTEDLVNLLPAILSPGALVVGVVCAAILRRHVGPGEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTQILSSLTITQLLKRLHQWINEDCSTPCSGSWLRDVWDWICTVLTDFKTWLQSKLLPRLPGVPFLSCQRGYKGVWRGDGIMQTTCPCGAQIAGHVKNGSMRIVGPRTCSNTWHGTFPINAYTTGPCTPSPAPNYSRALWRVAAEEYVEVTRVGDFHYVTGMTTDNVKCPCQVPAPEFFTEVDGVRLHRYAPACKPLLREDVTFQVGLNQYLVGSQLPCEPEPDVTVLTSMLTDPSHITAETAKRRLARGSPPSLASSSASQLSAPSLKATCTTHHDSPDADLIEANLLWRQEMGGNITRVESENKVVILDSFEPLHAEGDEREISVAAEILRKSRKFPSALPIWARPDYNPPLLESWKDPDYVPPVVHGCPLPPTKAPPIPPPRRKRTVVLTESNVSSALAELATKTFGSSGSSAVDSGTATALPDLASDDGDKGSDVESYSSMPPLEGEPGDPDLSDGSWSTVSEEASEDVVCCSMSYTWTGALITPCAAEESKLPINPLSNSLLRHHNMVYATTSRSASLRQKKVTFDRLQVLDDHYRDVLKEMKAKASTVKAKLLSIEEACKLTPPHSAKSKFGYGAKDVRNLSSRAVNHIRSVWEDLLEDTETPIDTTIMAKSEVFCVQPEKGGRKPARLIVFPDLGVRVCEKMALYDVVSTLPQAVMGSSYGFQYSPKQRVEFLVNTWKSKKCPMGFSYDTRCFDSTVTESDIRVEESIYQCCDLAPEARQAIRSLTERLYIGGPLTNSKGQNCGYRRCRASGVLTTSCGNTLTCYLKATAACRAAKLQDCTMLVNGDDLVVICESAGTQEDAAALRAFTEAMTRYSAPPGDPPQPEYDLELITSCSSNVSVAHDASGKRVYYLTRDPTTPLARAAWETARHTPINSWLGNIIMYAPTLWARMILMTHFFSILLAQEQLEKALDCQIYGACYSIEPLDLPQIIERLHGLSAFTLHSYSPGEINRVASCLRKLGVPPLRTWRHRARSVRAKLLSQGGRAATCGRYLFNWAVRTKLKLTPIPAASQLDLSGWFVAGYSGGDIYHSLSRARPRWFPLCLLLLSVGVGIYLLPNR</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell cytoplasm</CellLocal>
      <Ontology_ID>GO:0030430</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral envelope protein</CellLocal>
      <Ontology_ID>KW-0261</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0044167</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell perinuclear region of cytoplasm</CellLocal>
      <Ontology_ID>GO:0044220</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral envelope</CellLocal>
      <Ontology_ID>GO:0019031</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host mitochondrion</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion membrane</CellLocal>
      <Ontology_ID>GO:0055036</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell nucleus</CellLocal>
      <Ontology_ID>GO:0042025</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell mitochondrion</CellLocal>
      <Ontology_ID>GO:0033650</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral nucleocapsid</CellLocal>
      <Ontology_ID>GO:0019013</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell mitochondrial membrane</CellLocal>
      <Ontology_ID>GO:0044191</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell membrane</CellLocal>
      <Ontology_ID>GO:0033644</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host mitochondrion membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Ribonucleoprotein complex</CellLocal>
      <Ontology_ID>GO:0030529</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell plasma membrane</CellLocal>
      <Ontology_ID>GO:0020002</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell lipid particle</CellLocal>
      <Ontology_ID>GO:0044186</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell endoplasmic reticulum</CellLocal>
      <Ontology_ID>GO:0044165</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host lipid droplet</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral capsid</CellLocal>
      <Ontology_ID>GO:0019028</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host nucleus</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion</CellLocal>
      <Ontology_ID>GO:0019012</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cytoplasm</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Genbank_ACCN>D10750</Genbank_ACCN>
    <Protein_ACCN>BAA01583</Protein_ACCN>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P06240</Uniprot_ID>
      <Gene_Name>Lck</Gene_Name>
      <EBI_ID>EBI-1401</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-1401</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P07948</Uniprot_ID>
      <Gene_Name>LYN</Gene_Name>
      <EBI_ID>EBI-79452</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-79452</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P19525</Uniprot_ID>
      <Gene_Name>EIF2AK2</Gene_Name>
      <EBI_ID>EBI-640775</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-640775</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P08631</Uniprot_ID>
      <Gene_Name>HCK</Gene_Name>
      <EBI_ID>EBI-346340</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-346340</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P62993</Uniprot_ID>
      <Gene_Name>GRB2</Gene_Name>
      <EBI_ID>EBI-401755</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-401755</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P06241</Uniprot_ID>
      <Gene_Name>FYN</Gene_Name>
      <EBI_ID>EBI-515315</EBI_ID>
      <PPI_EBI_URL>EBI-710506,EBI-515315</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 4c</PDB_Title>
      <PDB_ID>3GNW</PDB_ID>
      <Resolution>2.39</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GNW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00898001</ASD_Ligand>
      <PubMed_Title>Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.</PubMed_Title>
      <Author>Vandyck, K., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4099-4102</Journal>
      <PubMed_ID>19507864</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase in complex with compound 6</PDB_Title>
      <PDB_ID>4JU1</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JU1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410432</ASD_Ligand>
      <PubMed_Title>Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.</PubMed_Title>
      <Author>Hucke, O., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1932-1943</Journal>
      <PubMed_ID>23773186</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with COMPOUND 2</PDB_Title>
      <PDB_ID>4JTY</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JTY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410428</ASD_Ligand>
      <PubMed_Title>Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.</PubMed_Title>
      <Author>Hucke, O., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1932-1943</Journal>
      <PubMed_ID>23773186</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase in complex with compound 9</PDB_Title>
      <PDB_ID>4JVQ</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JVQ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410464</ASD_Ligand>
      <PubMed_Title>Enantiomeric Atropisomers Inhibit HCV Polymerase and/or HIV Matrix: Characterizing Hindered Bond Rotations and Target Selectivity.</PubMed_Title>
      <Author>Laplante, S.R., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1944-1951</Journal>
      <PubMed_ID>24024973</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase in complex with compound 4</PDB_Title>
      <PDB_ID>4JTZ</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JTZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410430</ASD_Ligand>
      <PubMed_Title>Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.</PubMed_Title>
      <Author>Hucke, O., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1932-1943</Journal>
      <PubMed_ID>23773186</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure Analysis of PA3770</PDB_Title>
      <PDB_ID>4DQW</PDB_ID>
      <Resolution>2.51</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DQW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01140145;ASD00890024</ASD_Ligand>
      <PubMed_Title>MgATP Regulates Allostery and Fiber Formation in IMPDHs.</PubMed_Title>
      <Author>Labesse, G., et al.</Author>
      <Journal>Structure(2013)21:975-985</Journal>
      <PubMed_ID>23643948</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase in complex with coupound 1</PDB_Title>
      <PDB_ID>4JTW</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JTW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410426</ASD_Ligand>
      <PubMed_Title>Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.</PubMed_Title>
      <Author>Hucke, O., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1932-1943</Journal>
      <PubMed_ID>23773186</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase in complex with COMPOUND 29</PDB_Title>
      <PDB_ID>4JJU</PDB_ID>
      <Resolution>1.91</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JJU</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00890014</ASD_Ligand>
      <PubMed_Title>Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.</PubMed_Title>
      <Author>Beaulieu, P.L., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2013)23:4132-4140</Journal>
      <PubMed_ID>23768906</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase in complex with COMPOUND 2</PDB_Title>
      <PDB_ID>4JJS</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JJS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00890010</ASD_Ligand>
      <PubMed_Title>Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.</PubMed_Title>
      <Author>Beaulieu, P.L., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2013)23:4132-4140</Journal>
      <PubMed_ID>23768906</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase</PDB_Title>
      <PDB_ID>3MWW</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MWW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00890012</ASD_Ligand>
      <PubMed_Title>Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B.</PubMed_Title>
      <Author>LaPlante, S.R., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2010)132:15204-15212</Journal>
      <PubMed_ID>20942454</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase in complex with compound 12</PDB_Title>
      <PDB_ID>4JU2</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JU2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410440</ASD_Ligand>
      <PubMed_Title>Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.</PubMed_Title>
      <Author>Hucke, O., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1932-1943</Journal>
      <PubMed_ID>23773186</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 1b</PDB_Title>
      <PDB_ID>3GNV</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GNV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00898002</ASD_Ligand>
      <PubMed_Title>Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.</PubMed_Title>
      <Author>Vandyck, K., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4099-4102</Journal>
      <PubMed_ID>19507864</PubMed_ID>
    </PDB>
  </PDB_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00890024</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00898001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00898002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410426</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410428</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410430</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410432</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410440</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410464</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2014-05-15</Create_Date>
</Organism_Record>